DDMODEL00000005: Lledo-Garcia_2013_diabetes

Short description:
Population model of glycosylation of red blood cells to simulate the longitudinal relationship between HbA1c and mean plasma glucose in normal and diabetic subjects.
PharmML 0.8.x (0.8.1) |
|
|
|
Paolo Magni
|
Context of model development: | Clinical end-point; Mechanistic Understanding; |
Model compliance with original publication: | Yes; |
Model implementation requiring submitter’s additional knowledge: | No; |
Modelling context description: | HbA1c is the most commonly used biomarker for the adequacy of glycemic management in diabetic patients and a surrogate endpoint for anti-diabetic drug approval. In spite of an empirical description for the relationship between average glucose (AG) and HbA1c concentrations, obtained from the A1c-derived average glucose (ADAG) study by Nathan et al., a model for the non-steady-state relationship is still lacking. Using data from the ADAG study, we here develop such models that utilize literature information on (patho)physiological processes and assay characteristics. The model incorporates the red blood cell (RBC) aging description, and uses prior values of the glycosylation rate constant (KG), mean RBC life-span (LS) and mean RBC precursor LS obtained from the literature. Different hypothesis were tested to explain the observed non-proportional relationship between AG and HbA1c. Both an inverse dependence of LS on AG and a non-specificity of the National Glycohemoglobin Standardization Program assay used could well describe the data. Both explanations have mechanistic support and could be incorporated, alone or in combination, in models allowing prediction of the time-course of HbA1c changes associated with changes in AG from, for example dietary or therapeutic interventions, and vice versa, to infer changes in AG from observed changes in HbA1c. The selection between the alternative mechanistic models require gathering of new information.; |
Modelling task in scope: | simulation; |
Nature of research: | Clinical research & Therapeutic use; |
Therapeutic/disease area: | Endocrinology; |
Annotations are correct. |
|
This model is not certified. |
- Model owner: Paolo Magni
- Submitted: Sep 26, 2014 3:32:40 PM
- Last Modified: Oct 10, 2016 9:42:06 PM
Revisions
-
Version: 12
- Submitted on: Oct 10, 2016 9:42:06 PM
- Submitted by: Paolo Magni
- With comment: Update MDL syntax to the version 1.0 and R script to SEE version 2.0.0. Code automatically generated for NONMEM and MONOLIX
-
Version: 11
- Submitted on: Jun 2, 2016 8:27:17 PM
- Submitted by: Paolo Magni
- With comment: Model revised without commit message
-
Version: 10
- Submitted on: Jun 2, 2016 8:24:02 PM
- Submitted by: Paolo Magni
- With comment: Updated model annotations.
-
Version: 7
- Submitted on: Dec 11, 2015 12:36:07 PM
- Submitted by: Paolo Magni
- With comment: Edited model metadata online.
-
Version: 3
- Submitted on: Sep 26, 2014 3:32:40 PM
- Submitted by: Paolo Magni
- With comment: Model revised without commit message
Name
Generated from MDL. MOG ID: lledo2013_mog
Independent Variables
|
Function Definitions
|
Covariate Model:
Continuous Covariates
Parameter Model:
Random Variables
Population Parameters
Individual Parameters
Structural Model:
Variables
Observation Model:
Continuous Observation
External Dataset
OID
|
|
Tool Format
|
NONMEM
|
File Specification
Format
|
|
Delimiter
|
comma
|
File Location
|
Simulated_Dynamic_MPG.csv
|
Column Definitions
Column ID | Position | Column Type | Value Type |
---|---|---|---|
Column Mappings
Column Ref | Modelling Mapping |
---|---|
Estimation Step
OID
|
|
Dataset Reference
|
Parameters To Estimate
Parameter | Initial Value | Fixed? | Limits |
---|---|---|---|
pm.GAMMA |
true
|
||
pm.POP_LS |
true
|
||
pm.IIV_LS |
true
|
||
pm.POP_KG |
true
|
||
pm.POP_LSP |
true
|
||
pm.IIV_LSP |
true
|
||
pm.CV_HBA1C |
true
|
||
pm.OMEGA_LS |
true
|
||
pm.OMEGA_LSP |
true
|
||
pm.SIGMA_RES |
true
|
Operations
Operation:
Op Type
|
generic
|
Operation Properties
Name | Value |
---|---|
algo
|
Step Dependencies
Step OID | Preceding Steps |
---|---|